During the past three decades, percutaneous coronary intervention has become one of the
cardinal treatment strategies for stenotic coronary artery disease. Technical advances …

The management of intermediate coronary lesions, defined by a diameter stenosis of 40% to
70%, continues to be a therapeutic dilemma for cardiologists. The 2-dimensional …

Heart disease is the leading cause of death in the United States (1), and coronary artery
disease is the most common type of heart disease (2). The annual estimated cost of heart …

Complications of percutaneous coronary intervention (PCI) may have significant impact on
patient survival and healthcare costs. PCI procedural complexity and patient risk are …

Objectives: The goal of this study was to evaluate the safety and efficacy of nicardipine in
reversing no‐reflow during percutaneous coronary intervention (PCI). Background: No …

目的探讨急性心肌梗死(AMI) 患者急诊PCI 术后出现无复流的相关危险因素. 方法发病在6h
以内, 或12 h 内仍有持续胸痛的843 名AMI 患者给予急诊PCI, 收集患者的临床 …

Slow/no‐reflow phenomenon is a serious problem complicating primary percutaneous
coronary intervention (PCI) for acute myocardial infarction (AMI) and is associated with a …

No-reflow is one of the major causes of postinterventional rise of cardiac enzyme and
myocardial infarction (MI). This complication is associated with substantial morbidity and …

Previous studies have shown that transient no-reflow during coronary intervention but with
Thrombosis in Myocardial Infarction (TIMI) grade 3 flow at the completion of the procedure is …

The lack of reperfusion of myocardium after prolonged ischaemia that may occur despite
opening of the infarct-related artery is termed “no reflow”. No reflow or slow flow occurs in 3 …